Riik: Suurbritannia
keel: inglise
Allikas: MHRA (Medicines & Healthcare Products Regulatory Agency)
Nicorandil
Rivopharm (UK) Ltd
C01DX16
Nicorandil
10mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02060300; GTIN: 5060388650124
PACKAGE LEAFLET: INFORMATION FOR THE USER NICORANDIL 10 MG TABLETS NICORANDIL 20 MG TABLETS nicorandil READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Nicorandil is and what it is used for 2. What you need to know before you take Nicorandil 3. How to take Nicorandil 4. Possible side effects 5. How to store Nicorandil 6. Contents of the pack and other information 1. WHAT NICORANDIL IS AND WHAT IT IS USED FOR Nicorandil contains a medicine called nicorandil. This belongs to a group of medicines called “potassium channel activators”. It works by increasing the blood flow through the blood vessels of the heart. It improves the blood and oxygen supply of your heart muscle and reduces its workload. Nicorandil is used to prevent or attenuate painful, straining symptoms (angina pectoris) of your heart disease. It is used in adult patients who do not tolerate or cannot take heart medicines called beta- blockers and/or calcium antagonists. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE NICORANDIL DO NOT TAKE NICORANDIL: - If you are allergic to nicorandil or any of the other ingredients of this medicine (listed in section 6). - If you have low blood pressure (hypotension). - If you have heart problems such as cardiogenic shock, or left ventricular failure with low filling pressure or cardiac decompensation or shock. - If you are taking medicines to treat erectile dysfunction such as sildenafil, tadalfil, vardenafil (phosphodiesterase inhibitors) or medicines to treat pulmonary hypertension such as r Lugege kogu dokumenti
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Nicorandil 10mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10mg of nicorandil. For the full list of excipients, see Section 6.1 3 PHARMACEUTICAL FORM Tablet White, round, scored on one side and embossed on the other side with ’10’. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Nicorandil is indicated in adults for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or have a contraindication or intolerance to first-line antianginal therapies (such as beta- blockers and/or calcium antagonists_)_. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The usual therapeutic range is 10 to 20 mg twice daily. The usual starting dose is 10 mg twice daily (bid), in the morning and in the evening preferably. It is recommended that the dose be titrated upwards in accordance with the patient’s needs, response and tolerance up to 40 mg twice daily, if necessary. A lower starting dose of 5 mg twice daily may be used in patients particularly prone to headache. _ _ Elderly: There are no special dose requirements for elderly patients, but as with all medicines, _ use of the lowest effective dose is recommended._ _ _ _Patients with liver and/or renal impairment_ There are no special dosage requirements for patients with liver and/or renal impairment. _Paediatric population_ Nicorandil is not recommended in paediatric patients since its safety and efficacy have not been established in this patient group. Method of administration Nicorandil is administered by oral route. The tablets are to be swallowed in the morning and in the evening as a whole with some liquid. Administration is independent from food intake. 4.3 CONTRAINDICATIONS • Hypersensitivity to nicorandil or to any of the excipients listed in section 6.1 • Patients with shock (including cardiogenic shock), severe hypotension, or left ventricular dysfunction with low filling pressure or cardiac decompensation • Use of p Lugege kogu dokumenti